Technology Transfer Center of the National Cancer Institute
The National Cancer Institute's Small Business Innovation Research (NCI SBIR) Development Center released thirteen funding opportunities for FY2013
9/26/2012
Included are two NCI SBIR Technology Transfer (SBIR-TT) topics based on inventions from NCI intramural researchers: Topic 317: Wound Healing Preparations Incorporating Nitric Oxide-Releasing Materials; and Topic 318: Test to Predict Effectiveness of Docetaxel Treatment for Prostate Cancer. The SBIR-TT program awards small business contracts to translate NCI-invented technology towards commercialization. Additional details on the FY2013 contract funding opportunities are available at http://sbir.cancer.gov/funding/contracts/.
